Please check your internet connection and try again.
# Hyaluronic Acid
## Overview
Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan present in various connective tissues. It acts as a lubricant and shock absorber. Pharmaceutical preparations are typically synthetic or derived from microbial fermentation.
## Primary Indications
* **Ophthalmic Surgery:** Viscoelastic agent for intraocular lens implantation, cataract surgery, and corneal transplantation.
* **Osteoarthritis:** Intra-articular injection for symptomatic relief of knee osteoarthritis.
* **Wound Healing:** Topical formulations for promoting wound healing.
* **Dermal Fillers:** Injectable formulations for cosmetic enhancement (aesthetic use, typically not managed by clinical pharmacists).
## Adult Dosing
* **Ophthalmic Surgery:** Concentration and volume vary by product and surgical procedure. Examples include:
* Healon (1%): 0.25 mL to 2.0 mL per eye, depending on the procedure.
* Viscoat (3% HA / 4% chondroitin sulfate): 0.25 mL to 0.75 mL per eye.
* Specific volumes are guided by surgeon preference and surgical technique.
* **Osteoarthritis (Knee):** Intra-articular injection.
* Common preparations: 20 mg/2 mL (10 mg/mL).
* Typical regimen: One injection per week for 3 to 5 weeks.
* Maximum dose: Varies by product and protocol; consult specific product labeling.
* **Wound Healing:** Topical application as directed by product labeling.
## Pediatric Dosing
Dosing in pediatric populations for ophthalmic surgery or osteoarthritis is not well-established and should be based on expert consultation and extrapolation from adult data, with careful consideration of anatomical differences and potential risks.
## Dose Adjustments
No specific dose adjustments are typically required for renal or hepatic impairment for most commonly used formulations.
## Contraindications
* Hypersensitivity to hyaluronic acid or any component of the formulation.
* Active joint infection (for intra-articular injections).
* Skin infection at the injection site (for intra-articular injections).
## Adverse Effects
* **Ophthalmic:** Transient intraocular pressure elevation, anterior chamber inflammation, corneal edema, retinal detachment (rare).
* **Intra-articular:** Pain, swelling, stiffness at the injection site, arthralgia, transient joint effusion.
* **Topical:** Local irritation, redness.
## Key Drug Interactions
* **Ophthalmic:** Concurrent use with other intraocular medications may affect absorption or efficacy.
* **Intra-articular:** Concurrent use of topical anesthetics at the injection site is common. Avoid concurrent intra-articular administration of corticosteroids with HA preparations, as this may increase the risk of infection or joint damage; separate administration if necessary, guided by clinical judgment.
## Monitoring
* **Ophthalmic:** Intraocular pressure (IOP) post-operatively.
* **Intra-articular:** Patient-reported pain and function. Monitor for signs of infection or significant inflammatory response at the injection site.
## Clinical Pearls
* Hyaluronic acid preparations are available in various molecular weights and concentrations, affecting their viscoelastic properties and clinical use.
* For ophthalmic use, careful aspiration and injection technique are crucial to minimize complications.
* For intra-articular injections, proper sterile technique is paramount to prevent infection. Symptomatic relief may not be immediate and can take several weeks.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant guidelines before initiating or modifying drug therapy. Dosing and indications may vary based on specific product formulations and local institutional protocols.
